Autopsy report · NCT00605189

A Trial Examining Cellular Energetics Related to Various Wound Treatment Therapies

“Study no longer met business objectives”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months after it had already started.
• Ran for about 3 years 4 months before it stopped.
• 50 participants enrolled.
• Results were posted on the registry 8 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

KCI USA, Inc

Sponsor type

Industry

Conditions

Diabetic Foot Ulcers

Interventions

Powered Suction Pump (VAC Freedom); Powered Suction Pump; MWT

Participants

50

Sites

2

Countries

United States

Trials that died the same way

• A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
  “Study terminated due to business priorities” (73% match in meaning)
• TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
  “Study terminated for strategic business reasons” (72% match in meaning)
• The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B
  “Study terminated due to business and strategic decision” (71% match in meaning)
• Entecavir Plus Adefovir in Lamivudine-Resistant Patients
  “Business Objectives Changed” (70% match in meaning)
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
  “The study was terminated due to strategic business reasons.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.